Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.7271
-0.0150 (-2.02%)
At close: Aug 5, 2026, 4:00 PM EDT
0.7230
-0.0041 (-0.56%)
After-hours: Aug 5, 2026, 7:30 PM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $22.97 million as of August 5, 2026. Its market cap has decreased by -10.48% in one year.
Market Cap
22.97M
Enterprise Value
8.44M
1-Year Change
-10.48%
Ranking
Category
Stock Price
$0.73
ChartMarket Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $22.97M, a decrease of -86.68%. That is a compound annual growth rate of -30.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 22.97M | 112.84% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABVC BioPharma | 26.28M |
| Actinium Pharmaceuticals | 25.46M |
| Actuate Therapeutics | 25.36M |
| IGC Pharma | 24.53M |
| Barinthus Biotherapeutics | 24.51M |
| Quince Therapeutics | 24.41M |
| Evaxion | 23.27M |
| CEL-SCI | 21.85M |